MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 649.67
Enterprise Value ($M) 600.37
Book Value ($M) 241.15
Book Value / Share 4.86
Price / Book 2.69
NCAV ($M) 238.62
NCAV / Share 4.81
Price / NCAV 2.72

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 23.76
Current Ratio 23.76

Balance Sheet (mrq) ($M)
Current Assets 249.10
Assets 251.64
Liabilities 10.48
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -84.66
Net Income -71.90

Cash Flow Statement (mra) ($M)
Cash From Operations -81.17
Cash from Investing -160.47
Cash from Financing 203.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-15 13G TCG Crossover GP II, LLC 6.40
02-14 13G Adams Street Partners Llc 5.60
02-13 13G HBM Healthcare Investments (Cayman) Ltd. 5.50
02-13 13G Catalys Pacific Fund, LP 22.40
02-12 13D/A Samsara BioCapital, L.P. 10.30 12.61
02-12 13D/A Ra Capital Management, L.p. 9.99 55.59

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 9,501 57,783 16.44
2024-05-02 16,980 82,975 20.46
2024-05-01 18,988 356,664 5.32
2024-04-30 17,131 108,522 15.79
2024-04-29 7,122 20,479 34.78

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io